Genital Human Papillomavirus Prevalence Over the Lifespan Among Females and Males in a National Cross-Sectional Survey, United States, 2013–2016
Conclusions
Sex differences in age-specific non–vaccine-type HPV prevalence may reflect natural history and sexual behavior. Differences in vaccine-type and non–vaccine-type modeling results suggest vaccine impact as joinpoints occur in mid-late 20s for vaccine-type HPV but early 20s for nonvaccine types. These data can assist in refining HPV vaccination models and inform HPV vaccination practices and policy.
Source: Sexually Transmitted Diseases - Category: Sexual Medicine Tags: Original Studies Source Type: research
More News: Cervical Cancer Vaccine | Epidemiology | Genital Warts | Human Papillomavirus (HPV) | Nutrition | Sexual Medicine | STDs | Study | USA Health | Vaccines